ZERO Adds Community Health Charities Head and Vanderbilt Urology Professor to Board of Directors May 14, 2018 WASHINGTON, D.C. – ZERO added two new members to its Board of Directors this week, Kelvin Moses, M.D., Ph.D., FACS at Vanderbilt University and Thomas G. Bognanno, President & CEO at Community Health Charities. They join a growing robust and talented board of directors with diverse medical, nonprofit, and advocacy experience. “Dr. Moses and Mr. Bognanno are both extraordinary leaders in their respective medical and nonprofit communities and we are incredibly fortunate to have them fighting by our side to end prostate cancer,” said ZERO CEO Jamie Bearse. “Kelvin’s expertise will enable us better understand prostate cancer’s effects on families while Tom’s experience will help us make a greater impact in the nonprofit business space.”A member of ZERO’s Medical Advisory Board, Dr. Moses serves as an Assistant Professor of Urology in the Department of Urologic Surgery at Vanderbilt University Medical Center. He received both his M.D. and a Ph.D from the Baylor College of Medicine and is a foremost expert on prostate cancer in the African American community as well as the topic of cancer disparities in the United States. In his role on the Medical Advisory Board, Dr. Moses is a frequent speaker at the ZERO Annual Advocacy Summit, discussing topics ranging from what high-risk men should know about the disease to sexual health after treatment.Thomas Bognanno is a prostate cancer survivor and has been the President and CEO of Community Health Charities since January 2006. He is a career nonprofit executive and the catalyst for bringing Community Health Charities to the next level with innovative programs that focus on employee engagement, workplace giving campaigns, and health resources. In his role he utilizes his decades of experience and expertise to define strategic direction and increase income for Community Health Charities’ member organizations. Prior to his current position, Tom spent 20 years with the American Diabetes Association. His personal experience battling prostate cancer provides a valuable patient perspective as ZERO continues to expand its patient support programs.ZERO’s Board of Directors also includes Robert Ginyard, Dr. Alicia Morgans, Col. Paul Taylor, Sherry Galloway, R.N., Leo Giambarresi, Ph.D., Jonathan D. Schwartz, Cheryl Nikituk, Tom Hulsey, and Ed Lomasney. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org About ZERO Press Release More for you
ZERO Adds Community Health Charities Head and Vanderbilt Urology Professor to Board of Directors May 14, 2018
WASHINGTON, D.C. – ZERO added two new members to its Board of Directors this week, Kelvin Moses, M.D., Ph.D., FACS at Vanderbilt University and Thomas G. Bognanno, President & CEO at Community Health Charities. They join a growing robust and talented board of directors with diverse medical, nonprofit, and advocacy experience. “Dr. Moses and Mr. Bognanno are both extraordinary leaders in their respective medical and nonprofit communities and we are incredibly fortunate to have them fighting by our side to end prostate cancer,” said ZERO CEO Jamie Bearse. “Kelvin’s expertise will enable us better understand prostate cancer’s effects on families while Tom’s experience will help us make a greater impact in the nonprofit business space.”A member of ZERO’s Medical Advisory Board, Dr. Moses serves as an Assistant Professor of Urology in the Department of Urologic Surgery at Vanderbilt University Medical Center. He received both his M.D. and a Ph.D from the Baylor College of Medicine and is a foremost expert on prostate cancer in the African American community as well as the topic of cancer disparities in the United States. In his role on the Medical Advisory Board, Dr. Moses is a frequent speaker at the ZERO Annual Advocacy Summit, discussing topics ranging from what high-risk men should know about the disease to sexual health after treatment.Thomas Bognanno is a prostate cancer survivor and has been the President and CEO of Community Health Charities since January 2006. He is a career nonprofit executive and the catalyst for bringing Community Health Charities to the next level with innovative programs that focus on employee engagement, workplace giving campaigns, and health resources. In his role he utilizes his decades of experience and expertise to define strategic direction and increase income for Community Health Charities’ member organizations. Prior to his current position, Tom spent 20 years with the American Diabetes Association. His personal experience battling prostate cancer provides a valuable patient perspective as ZERO continues to expand its patient support programs.ZERO’s Board of Directors also includes Robert Ginyard, Dr. Alicia Morgans, Col. Paul Taylor, Sherry Galloway, R.N., Leo Giambarresi, Ph.D., Jonathan D. Schwartz, Cheryl Nikituk, Tom Hulsey, and Ed Lomasney.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
